Search | IOVS | ARVO Journals

Showing 1 – 20 of 33

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Relative contributions of imaging markers of poor visual acuity in retinal vascular diseases.

Piyali Sen; Joan Nunez Do Rio; Manjula Nugawela; Ahmed M Hagag; Philip G Hykin; Akanksha Bagchi; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1888. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Efficacy of Intravitreal Aflibercept Administered using Treat-and-Extend Regimen over 2 Years in Patients with Neovascular Age-Related Macular Degeneration: 1-Year ARIES Results.

Paul Mitchell; Eric H Souied; Edoardo Midena; Frank G Holz; Philip G Hykin; Sebastian Wolf; Helmut Allmeier

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):117. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Treatment response based on topography of retinal neovascularization in proliferative diabetic retinopathy

Sandra Halim; Amy A Kirkwood; Tunde Peto; Usha Chakravarthy; Jayashree Ramu; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6555. doi: https://doi.org/

Retina May 2019

The Relationship Between Retinal Vessel Oxygenation and Spatial Distribution of Retinal Nonperfusion in Retinal Vascular Diseases

PDF

Luke Nicholson; Clara Vazquez-Alfageme; Philip G. Hykin; James W. Bainbridge; Sobha Sivaprasad
TAGS: alveolar ventilation function, oximetry, retinal vessels, cell respiration, retinal vascular disorders
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):2083-2087. doi: https://doi.org/10.1167/iovs.18-24917

Retina August 2018

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

PDF

Luke Nicholson; Roxanne Crosby-Nwaobi; Joana C. Vasconcelos; A. Toby Prevost; Jayashree Ramu; Amy Riddell; James W. Bainbridge; Philip G. Hykin; Sobha Sivaprasad
TAGS: oximetry, eye, proliferative diabetic retinopathy, panretinal photocoagulation, aflibercept
Invest. Ophthalmol. Vis. Sci.. 2018; 59(10):4277-4284. doi: https://doi.org/10.1167/iovs.17-23509

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

A Multicentre Double-masked Randomised Controlled Non-Inferiority Trial comparing clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion [LEAVO]: Baseline patient sociodemographic and ocular characteristics.

Philip G Hykin; Joana Vasconcelas; Toby Prevost; Sobha Sivaprasad; Barry Hounsome; Usha Chakravarthy; Simon Harding; Andrew Lotery; Yit C. Yang; Piyali Sen; Jayashree Ramu; Luke Nicholson; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2569. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naïve Patients with Neovascular Age-related Macular Degeneration

Maria Eleftheriadou; Maria K Gemenetzi; Sobha Sivaprasad; Philip G Hykin; Robin Hamilton; Adnan Tufail; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):874. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum

Panagiotis Vasilopoulos; Andrew R Webster; Catherine A Egan; Hemal Mehta; Philip G Hykin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4639. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

The distribution of macular pigment in different macular diseases

Roy Schwartz; Roxanne Crosby-Nwaobi; Adam M Dubis; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4818. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration

Maria Cristina Citu; Roxanne R Crosby-Nwaobi; Maria Eleftheriadou; Clara Vazquez-Alfageme; Luke Nicholson; Sobha Sivaprasad; Philip Hykin; Robin D Hamilton

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3342. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Efficacy of Aflibercept in Treatment-naïve Neovascular Age-related Macular Degeneration: Two-Year Real World Outcomes

Maria Eleftheriadou; Clara Vazquez-Alfageme; Maria Cristina Citu; Roxanne R Crosby-Nwaobi; Sobha Sivaprasad; Philip Hykin; Robin D Hamilton; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3355. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Evolution of Short-wavelength Autofluorescence changes in Central Serous Chorioretinopathy over 12 months.

Marta Zola; Priyanka Sanghi; Namritha Patrao; Deepthy Menon; Philip Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3398. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Retinal non-perfusion in the posterior pole determines risk of neovascularisation in central retina vein occlusion

Luke Nicholson; Clara Vazquez-Alfageme; Namritha Valerie Patrao; Ioanna Triantafyllopoulou; Philip Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Significance of Choroidal Hyper-reflective foci visualised on Enhanced Depth Imaging in Central Serous Chorioretinopathy

Namritha Valerie Patrao; Deepthy Menon; Marta Zola; Priyanka Sanghi; Luke Nicholson; Philip Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4234. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Changes in Disorganization of Retinal Inner Layers (DRIL) Predict Retinal Sensitivity in Eyes with Diabetic Macular Edema

Timothy Peiris; Oliver Comyn; Luke Nicholson; Amanda Delacruz; Migil Ledesma; Philip Hykin; Sobha Sivaprasad; Paolo Sandico Silva; Lloyd Paul Aiello; Jennifer K Sun

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Central serous chorioretinopathy in women

Priyanka Sanghi; Marta Zola; Deepthy Menon; Namritha Patrao; Jayashree Ramu; Philip Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2157. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

Clinical, OCT and FFA characteristics of patients losing >5 letters BCVA following intravitreal ranibizumab therapy for diabetic macular oedema

Sheelah Antao; Namritha Patrao; Dawn Sim; Philip Hykin; Sobha Sivaprasad; Robin Hamilton; Catherine A Egan; James W B Bainbridge; Richard Andrews; Ranjan Rajendram

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1740. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

Real-world outcomes of Ranibizumab treatment for Diabetic Macular Oedema

Namritha Valerie Patrao; Sheelah Antao; Dawn A Sim; Sobha Sivaprasad; Richard Andrews; Robin Hamilton; Catherine A Egan; Adnan Tufail; Philip G Hykin; Ranjan Rajendram

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3148. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

Disease outcome in central serous chorioretinopathy patients with and without treatment

Jayashree Ramu; Luke Nicholson; Mahdi Muwas; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3727. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

Real-world UK NHS outcomes of a switch to Aflicercept from Ranibizumab in Neovascular age related macular degeneration (nvAMD).

Maria Cristina Citu; Roxanne R Crosby-Nwaobi; Philip G Hykin; Robin Hamilton; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4582. doi: https://doi.org/

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Relative contributions of imaging markers of poor visual acuity in retinal vascular diseases.

Efficacy of Intravitreal Aflibercept Administered using Treat-and-Extend Regimen over 2 Years in Patients with Neovascular Age-Related Macular Degeneration: 1-Year ARIES Results.

Treatment response based on topography of retinal neovascularization in proliferative diabetic retinopathy

The Relationship Between Retinal Vessel Oxygenation and Spatial Distribution of Retinal Nonperfusion in Retinal Vascular Diseases

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naïve Patients with Neovascular Age-related Macular Degeneration

Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum

The distribution of macular pigment in different macular diseases

Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration

Efficacy of Aflibercept in Treatment-naïve Neovascular Age-related Macular Degeneration: Two-Year Real World Outcomes

Evolution of Short-wavelength Autofluorescence changes in Central Serous Chorioretinopathy over 12 months.

Retinal non-perfusion in the posterior pole determines risk of neovascularisation in central retina vein occlusion

Significance of Choroidal Hyper-reflective foci visualised on Enhanced Depth Imaging in Central Serous Chorioretinopathy

Changes in Disorganization of Retinal Inner Layers (DRIL) Predict Retinal Sensitivity in Eyes with Diabetic Macular Edema

Central serous chorioretinopathy in women

Clinical, OCT and FFA characteristics of patients losing >5 letters BCVA following intravitreal ranibizumab therapy for diabetic macular oedema

Real-world outcomes of Ranibizumab treatment for Diabetic Macular Oedema

Disease outcome in central serous chorioretinopathy patients with and without treatment

Real-world UK NHS outcomes of a switch to Aflicercept from Ranibizumab in Neovascular age related macular degeneration (nvAMD).

To View More...

You must be signed into an individual account to use this feature.